Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Blood pressure lowering effects of losartan, moxonidine, and low sodium diet in formerly pre-eclamptic women
NL-OMON28431Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of losartan and moxonidine in hypertension (HTN) (4 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Mean ambulatory systolic and diastolic blood pressure. Started Dec 2015; status: active, not recruiting.
02
Drugs
losartanmoxonidine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NL-OMON28431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON28431.